During a Case-Based Roundtable® event, Andrew Yee, MD, discussed myeloma treatment strategies for different age groups, focusing on personalized regimens and the pros and cons of CAR T-cell therapy and bispecific antibodies in the second article of a 2-part series. Targeted Oncology: Why is achieving a quicker response particularly...

Tailoring Regimens for Different Age Groups With Multiple Myeloma

Rahul Banerjee, MD, FACP, discusses key takeaways from his presentation at an OncLive State of the Science Summit on multiple myeloma. Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutch Cancer Center; member, the International Myeloma Working Group; assistant professor, Division of Hematology and Oncology, University of Washington, discusses key takeaways from the presentation he gave at an OncLive® State of the Science Summit™ on multiple myeloma, highlighting the disease’s evolving treatment paradigm.

Dr Banerjee on the Evolving Multiple Myeloma Treatment Paradigm

Healthline

Hard palate cancer is rare and forms on the roof of your mouth. Learn more.

What to Know About Hard Palate Cancer

The first therapy that uses gene-editing is to be offered on the NHS in a “revolutionary breakthrough” for patients. It will be used as a potential cure for the blood disorder beta thalassaemia. Stem cells which make blood will be extracted, reprogrammed to correct the condition and returned...

First gene-editing therapy may cure blood disorder

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. It can progress slowly and may not cause many symptoms. Although it is treatable, it’s not considered to be curable. In the early stages, CLL often doesn't require treatment immediately, as studies have...

Chronic Lymphocytic Leukemia (CLL): When to Treat Cancer or Hold Off

Birmingham, AL

As a registered dietitian and avid runner, Beth Kitchin has had a healthy routine all her life. She ate well, loved to jog, hike and lift weights, ran a couple of marathons, and practiced yoga and tai chi. Kitchin had “absolutely” no health problems — until she started feeling a nagging pain in one of her legs in the fall of 2020.

Woman shocked leg pain is blood cancer symptom, requires 'red devil' chemo

Ontario, CA

César Serrano went from having trouble breathing to learning that he only had three months to live. The asthma medication his doctor prescribed wasn’t helping, so he ordered a CT scan and biopsy, which led to his stage-four lung cancer diagnosis. "Honestly, no one's prepared for something like...

He thought he only had months to live, but a new cancer test changed that

The Oklahoma City Sentinel

(StatePoint) A bladder cancer diagnosis can be scary, but according to those who’ve been through it, advocating for yourself and taking charge of your journey can help you make informed decisions when it comes to your treatment to get the best care possible.
                “For me, a second opinion turned an originally doom-and-gloom picture into a more hopeful, optimistic and clear path forward,” said Mary Beth M., a bladder cancer survivor. “It’s so important to seek a second or even a third opinion if you feel...

What to Know After a Bladder Cancer Diagnosis

Diabetic nephropathy is a form of long-term, chronic kidney disease resulting from having had diabetes for several years. Diabetes causes higher-than-normal blood glucose levels, which damage some of the kidney’s blood vessels over time. Damaged blood vessels in the kidneys and other factors, like inflammation, lead to kidney damage.

Exploring the Impact of Diabetic Nephropathy on Kidney Health

A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration. The Food and Drug Administration (FDA) has granted a fast track designation to a dendritic cell vaccine for the treatment of patients with pancreatic ductal adenocarcinoma. Immuno-oncology company Diakonos Oncology Corporation announced the designation...

FDA Fast Tracks Pancreatic Cancer Vaccine

In 1972, Janet Rowley sat at her dining room table and cut tiny chromosomes from photographs she had taken in her laboratory. One by one, she snipped out the small figures her children teasingly called paper dolls. She then carefully laid them out in 23 matching pairs—and warned her kids not to sneeze.

Path to precision: Targeted cancer drugs go from table to trials to bedside

Everyday Health

Learn about eosinophilic esophagitis (EoE) and its symptoms, including chronic cough, treatment options, and diagnosis methods.

Can Eosinophilic Esophagitis Be the Reason Behind Your Chronic Cough?

Savannah, GA

Contributors represent independent, third-party users who have joined our contributor program and self-verified their accounts. They have also demonstrated their experience writing hard news for other outlets. Contributors are expected, like all users, to adhere to our Community Standards.

contributor

Daily Coffee Press

Newly returned indictments in the Southern District of Georgia include felony charges for illegal firearms possession and drug distribution, while additional defendants have been sentenced to federal prison or await further proceedings after pleading guilty to federal gun charges.

Federal Charges in Southern GA: Indictments and Sentences for Firearms and Drug Offenses

SurvivorNet

Corey Rhodes, 32, is keeping himself as healthy and active as possible while living with an advanced rare liver cancer. Now that his tumors have 'stabilized,' he is helping comfort others affected by the disease while rallying his community to assist with cancer research efforts.

Heartburn and Shoulder Pain Led to 32-Year-Old’s Rare Liver Cancer Diagnosis: Tumor the Size of a ‘Deflated Basketball’

Approval marks the first time an immuno-oncology regimen has demonstrated a survival benefit for all adults with primary advanced or recurrent endometrial cancer, company says. The FDA has approved an expanded indication for GSK’s Jemperli (dostarlimab) to include treatment of all adults with primary advanced or recurrent endometrial cancer. According...

FDA Expands Approval of GSK’s Jemperli in Combination with Chemotherapy for Adults with Primary Advanced or Recurrent Endometrial Cancer

Ocilla, GA

Last Thursday, agents from the South Central Drug Task Force (SCDTF) made an arrest following a successful execution of a search warrant at a residence in Ocilla. According to officials, the search yielded a significant quantity of drugs, including tablets suspected to contain fentanyl, associated with a criminal street gang.

Successful Drug Bust in Ocilla Leads to Arrest Linked to 'Local Criminal Street Gang'

In the phase II CUPISCO trial reported in The Lancet, Krämer et al found that molecularly guided therapy in patients with unfavorable nonsquamous cancer of unknown primary who had disease control on first-line platinum-based therapy resulted in better progression-free survival vs patients who continued chemotherapy. Study Details. In the...

Cancer of Unknown Primary: Molecularly Guided Therapy After Disease Control on Platinum-Based Chemotherapy

From Patti Yasutake’s death from cancer to Olympic water polo player’s husband’s rare cancer diagnosis, here’s what’s happening in the oncology space this week. “Star Trek” actress died of cancer. Patti Yasutake, known for her roles as Nurse Alyssa Ogawa from the “Star Trek”...

‘Star Trek’ Actress Dies of Cancer, Olympian Reveals Husband’s Cancer and More

Tracie Mills, from Rugby, has been nominated for a BBC Make a Difference award.

Woman with terminal cancer raises £128k for NHS

The FDA on Thursday signed off on Citius Pharmaceuticals’ Lymphir (denileukin diftitox-cxdl) for the treatment of patients with relapsed or refractory cutaneous T cell lymphoma, who have undergone at least one prior line of systemic therapy. Lymphir is Citius’ first FDA-approved product and currently the only treatment for cutaneous...

Citius Scores FDA Approval in Cutaneous T Cell Lymphoma

NewsBreak

My Decision to Receive CAR-T Cell Therapy for Multiple Myeloma

I decided to receive CAR-T cell therapy for multiple myeloma when my previous regimen stopped working and now, I'm living my best life. Following an infection...

My Decision to Receive CAR-T Cell Therapy for Multiple Myeloma

Comments / 0